MedTrace Logo

Rapid Blood Culture Identification Panel in Pediatric Patients in Guatemala

NCT05314816 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 479

Last updated 2024-06-14

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to assess the clinical impact of a rapid multiplex PCR blood culture identification panel on time to optimal antimicrobial therapy when compared to conventional microbiological culture methods in children hospitalized in a low resource setting in Guatemala City.

Conditions

Interventions

DIAGNOSTIC_TEST

Blood culture identification panel

multiplex PCR panel to be performed on positive blood cultures

Sponsors & Collaborators

  • BioFire Diagnostics, LLC

    collaborator INDUSTRY

  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • Samuel Dominguez, MD, PhD · University of Colorado, Denver

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-07
Primary Completion
2022-11-11
Completion
2022-11-28
FDA Device
Yes

Countries

  • Guatemala

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05314816 on ClinicalTrials.gov